Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
ELVN
Enliven Therapeutics, Inc.
NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close
$45.84
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
PHARMACEUTICAL PREPARATIONS
Market cap
$3.36B
Country
USA
RECENT INSIDER TRADES
2026-10-05
· Garland J. Scott
(Director)
· SELL
2026-10-05
· Garland J. Scott
(Director)
· OTHER
2026-09-21
· Hohl Benjamin
(CHIEF FINANCIAL OFFICER)
· SELL
2026-09-21
· Collins Helen Louise
(CHIEF MEDICAL OFFICER)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
225
Shares held
86,550,808
Value
$4.01B
Percent of shares outstanding
118.12%
As of quarter end
2026-06-30
RECENT NEWS
Enliven Therapeutics director Scott Garland sells $606k in stock
Guggenheim reiterates Enliven Therapeutics stock rating on FDA alignment
ELVN: Enliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic Myeloid Leukemia
Morgan Stanley initiates Enliven Therapeutics stock at overweight
Enliven Therapeutics stock initiated at Overweight by JPMorgan
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Enliven Therapeutics, Inc. (ELVN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit